AHC
MRK icon

Adell Harriman & Carpenter’s Merck MRK Stock Holding History

Adell Harriman & Carpenter’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.48M Sell
12,302
-310
-2% -$35.8K 0.09% 94
2025
Q4 		$1.33M Sell
12,612
-1,665
-12% -$156K 0.08% 99
2025
Q3 		$1.2M Sell
14,277
-3,923
-22% -$323K 0.07% 99
2025
Q2 		$1.44M Sell
18,200
-4,775
-21% -$380K 0.1% 97
2025
Q1 		$2.06M Sell
22,975
-15,764
-41% -$1.47M 0.16% 87
2024
Q4 		$3.85M Sell
38,739
-24,908
-39% -$2.57M 0.27% 68
2024
Q3 		$7.23M Buy
63,647
+10,210
+19% +$1.21M 0.53% 49
2024
Q2 		$6.62M Buy
53,437
+13,670
+34% +$1.76M 0.51% 48
2024
Q1 		$5.25M Buy
39,767
+8,156
+26% +$1.01M 0.43% 57
2023
Q4 		$3.45M Buy
31,611
+5,352
+20% +$556K 0.32% 70
2023
Q3 		$2.7M Buy
26,259
+6,835
+35% +$737K 0.28% 73
2023
Q2 		$2.22M Buy
19,424
+3,350
+21% +$380K 0.23% 81
2023
Q1 		$1.71M Buy
16,074
+2,770
+21% +$299K 0.18% 87
2022
Q4 		$1.48M Buy
13,304
+711
+6% +$72.7K 0.17% 89
2022
Q3 		$1.08M Buy
12,593
+5,150
+69% +$460K 0.13% 97
2022
Q2 		$679K Buy
7,443
+3,794
+104% +$336K 0.08% 98
2022
Q1 		$299K Buy
3,649
+768
+27% +$60.6K 0.03% 150
2021
Q4 		$221K Sell
2,881
-288
-9% -$22.9K 0.02% 171
2021
Q3 		$238K Buy
+3,169
New +$241K 0.02% 169
2015
Q3 		– Sell
-5,501
Closed -$299K – 142
2015
Q2 		$299K Sell
5,501
-1,886
-26% -$106K 0.08% 125
2015
Q1 		$405K Buy
7,387
+632
+9% +$35.8K 0.11% 111
2014
Q4 		$366K Buy
6,755
+314
+5% +$17.5K 0.1% 109
2014
Q3 		$356K Hold
6,441
– – 0.1% 110
2014
Q2 		$356K Buy
6,441
+572
+10% +$31.2K 0.1% 110
2014
Q1 		$318K Buy
5,869
+792
+16% +$41K 0.09% 107
2013
Q4 		$242K Sell
5,077
-477
-9% -$21.8K 0.08% 120
2013
Q3 		$252K Buy
5,554
+471
+9% +$21.5K 0.07% 114
2013
Q2 		$225K Buy
+5,083
New +$227K 0.08% 112

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adell Harriman & Carpenter's MRK Position: Q1 2026 in Review

Adell Harriman & Carpenter reduced its Merck (MRK) stake by 2.5% in Q1 2026, selling an estimated $35.8K and leaving 12,302 shares worth $1.48M. The position accounts for 0.09% of the portfolio, ranked #94.

Adell Harriman & Carpenter first reported a position in MRK in Q2 2013 and has held it in 28 quarters since. The position peaked at $7.23M in Q3 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Adell Harriman & Carpenter held 12,302 shares of Merck worth $1.48M as of Q1 2026.
  • Adell Harriman & Carpenter sold 310 Merck shares in Q1 2026, an estimated $35.8K.
  • Merck made up 0.09% of Adell Harriman & Carpenter's portfolio in Q1 2026, its #94 holding.
  • Adell Harriman & Carpenter first reported a position in Merck in Q2 2013 and has held it in 28 quarters since.
  • Adell Harriman & Carpenter's Merck position peaked at $7.23M in Q3 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Adell Harriman & Carpenter's 13F filing for Q1 2026, filed 4 May 2026.